These limitations of the BTNX NTS are very applicable, as we identified e.g. etodesnitazene to own an identical in vitro potency and efficacy as fentanyl [7, 13] and as it may possibly give PWUD a Wrong perception of safety. On top of that, the detectability of nitazene analogues in drug samples could be impacted by solubility difficulties, as high